Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Barrett

Showing results (281-290 of 349) with videos related to

Pageof 35
Sort By:
Blood|May 5, 2007
Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host diseaseStephan Mielke, Katayoun Rezvani, Bipin N Savani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 21, 2015
CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantationAnkit Anand, Prathima Anandi, Natasha A Jain, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34<sup>+</sup> Selection versus CD3<sup>+</sup>/19<sup>+</sup> Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell TransplantationCaroline R Cantilena, Sawa Ito, Xin Tian, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyemaBrad Moriyama, Marisa Ditullio, Eleanor Wilson, et al.
Stem Cells (Dayton, Ohio)|January 24, 2014
Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responsesFang Yin, Minoo Battiwalla, Sawa Ito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignanciesStephan Mielke, Zachariah A McIver, Aarthy Shenoy, et al.
Blood|October 24, 2002
High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopeniaRichard D Huhn, Patrick F Fogarty, Ryotaro Nakamura, et al.
Blood|March 23, 2011
Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantationRobert Quan Le, J Joseph Melenhorst, Minoo Battiwalla, et al.
Clinical Hematology International|October 1, 2021
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus InstrumentSandhya R Panch, Opal L Reddy, Katherine Li, et al.
Clinical Hematology International|October 1, 2021
Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant SurvivorsNatasha A Jain, Marcus Y Chen, Sujata Shanbhag, et al.
Pageof 35

Showing results (281-290 of 349) with videos related to

Sort By:
Pageof 35
Blood|May 5, 2007
Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host diseaseStephan Mielke, Katayoun Rezvani, Bipin N Savani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 21, 2015
CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantationAnkit Anand, Prathima Anandi, Natasha A Jain, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34<sup>+</sup> Selection versus CD3<sup>+</sup>/19<sup>+</sup> Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell TransplantationCaroline R Cantilena, Sawa Ito, Xin Tian, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyemaBrad Moriyama, Marisa Ditullio, Eleanor Wilson, et al.
Stem Cells (Dayton, Ohio)|January 24, 2014
Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responsesFang Yin, Minoo Battiwalla, Sawa Ito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignanciesStephan Mielke, Zachariah A McIver, Aarthy Shenoy, et al.
Blood|October 24, 2002
High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopeniaRichard D Huhn, Patrick F Fogarty, Ryotaro Nakamura, et al.
Blood|March 23, 2011
Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantationRobert Quan Le, J Joseph Melenhorst, Minoo Battiwalla, et al.
Clinical Hematology International|October 1, 2021
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus InstrumentSandhya R Panch, Opal L Reddy, Katherine Li, et al.
Clinical Hematology International|October 1, 2021
Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant SurvivorsNatasha A Jain, Marcus Y Chen, Sujata Shanbhag, et al.
Pageof 35